Meine Zukunft Innovative Chemie Interviews Inspirierende Job-Links Meine Ausbildung

PAA Laboratories GmbH

Firmenlogo

For more than 20 years PAA Laboratories is a leading supplier and manufacturer of media, sera, reagents, buffer solutions and human blood products for all cell culture and diagnostic applications. Production facilities and sales offices in Europe, America and Australia and more than 50 distributors provide PAA with maximum flexibility to meet the requirements of its valued customers. PAA’s products are used in all areas where cell culture is performed including academic R&D (universities, hospitals) and private research institutes. In addition, PAA is a major supplier to the biopharmaceutical industry for the production of vaccines, therapeutic proteins and diagnostics. PAA’s FDA registered and GMP licensed facility in Pasching (Austria) is one of the most advanced facilities of its kind in the world. It is currently the only cell culture company being granted a Pharmaceutical Drug License. PAA possesses also the technical and scientific know how to satisfy customer specific requirements in terms of special product manufacturing and customized fillings. The R&D Department is currently working on the development of new innovative serum free cell culture media as well as special media for the production of Advanced Therapy Medicinal Products (ATMP).

News Focussing on Members

(AVIR Green Hills Biotechnology AG) deltaFLU –innovative vaccines for intranasal spray delivery or oral administration more 

 

(Apeptico) APEPTICO Announces Successful Completion of Phase I Trial with AP301 in Oedematous Respiratory Failure  more 

 

(Intercell) Intercell announces new management structure more 

 

(Eucodis) EUCODIS Bioscience and evocatal enter into alliance more 

 

(Intercell) Staph Bakali new Chief Business Officer more 

 

(Intercell) Intercell acquires antibody technology platform to further exploit its capabilities to combat infectious diseases more 

 

(Apeptico) APEPTICO granted Orphan Drug Designation by FDA for development compound AP301 more